Cargando…

A case series of autologous platelet-rich plasma injection in treating chronic ulcers conducted in Saudi Arabia

OBJECTIVE: This is a case series study of 14 cases of chronic unhealed ulcers involving patients of 19–85 years, aimed to demonstrate the positive therapeutic outcomes of using autologous platelet rich plasma (PRP) in diabetic foot ulcer (DFU) and other chronic wound healing. METHODS: This is a form...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabanjeh, Sinan F., Al-Malki, Talal, Kharabsheh, Rola Al, Mahmood, Danish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Qassim Uninversity 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986877/
https://www.ncbi.nlm.nih.gov/pubmed/36891041
Descripción
Sumario:OBJECTIVE: This is a case series study of 14 cases of chronic unhealed ulcers involving patients of 19–85 years, aimed to demonstrate the positive therapeutic outcomes of using autologous platelet rich plasma (PRP) in diabetic foot ulcer (DFU) and other chronic wound healing. METHODS: This is a formal consecutive clinical case series. Patients with chronic unhealed ulcers were enrolled from the amputation prevention clinic by an interdisciplinary team includes podiatrist, general surgeon, orthopedic, vascular surgeon, and wound care nurses at Kahel Specialized Centre, a specialized center for managing foot and ankle diseases, located in Riyadh, Saudi Arabia. Those patients who presented with chronic wounds and showed no significant wound reduction despite following the standard wound care protocol were included in the study. There were no specific predetermined exclusion criteria when considering patients for treatment with this modality. RESULTS: In this case series, majority (80%) of the patients were above 50 years of age, and 10 (66.7%) patients were male and 5 (33.3%) were female. Of all the cases presented to the amputation prevention clinic, majority (73.3%) reported suffering from type 2 diabetes mellitus (DM) and also, one reported type 1 DM [6.7%]). All the cases of DFU received a combination of hydrogel and autologous PRP treatment and were put of suitable offloading devices, except one case received a combination of Cadexomer iodine, hydrogel and PRP treatment. In the present case series involving 3–14 weeks of the treatment duration, only 2–3 doses of autologous PRP provided complete healing and or maximum wound closure. CONCLUSION: Autologous PRP therapy is efficacious in facilitating, enhancing wound healing and aids in complete wound closure. This case series was limited in term of the sample size which is the number patients enrolled for the study, hence, the study finding remain inconclusive to some extent and hence, further study is required with greater number of sample size. The strength of this study is that it is the first study in Saudi Arabia and gulf region, to report the beneficial effect of PRP in chronic unhealed ulcers including diabetic ulcers.